Ignite Creation Date:
2025-12-24 @ 4:57 PM
Ignite Modification Date:
2026-01-27 @ 12:15 PM
Study NCT ID:
NCT02756650
Status:
COMPLETED
Last Update Posted:
2020-06-11
First Post:
2016-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06-23
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-31
First Submit QC Date:
None
Study First Post Date:
2016-04-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-01-31
Results First Submit QC Date:
None
Results First Post Date:
2020-06-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-28
Last Update Post Date:
2020-06-11
Last Update Post Date Type:
ACTUAL